FoLSM - A year in review - May

King's student wins prestigious essay award from British Pharmacological Society

Jade Pullen, a second year BSc Pharmacology student, has been named winner of the British Pharmacological Society’s Early Career Pharmacologist Essay Competition for her writing on the psychedelic drug Ibogaine. We caught up with her to discuss her award-winning essay, and her journey into pharmacology.

Read the full story

UK first: baby brain images can reveal new insights into disease processes

Researchers and clinicians have scanned new-born babies in an ultra-high-field strength 7T MRI scanner for the first time in the UK.

This advance allows several new opportunities to gain important new information with neonatal imaging, such as the early identification of neurodevelopmental disorders and new insight into the underlying disease processes.

Read the full story

First death in the UK associated with Xylazine

The death of a 43-year-old male is the first in the UK to be associated with Xylazine and marks the entry of the drug into the UK drug supply.

New research published in the Journal of Forensic and Legal Medicine by academics from King's details the death of the man in May 2022 from the effects of Xylazine alongside heroin, fentanyl and cocaine.

Read the full story

AI model predicts if breast cancer will spread based on lymph node changes

Artificial intelligence (AI) can predict if an aggressive type of breast cancer will spread based on changes in a patient’s lymph nodes.

The research, published today in The Journal of Pathology, by Breast Cancer Now funded scientists at King’s, shows that by analysing the immune responses in the lymph nodes of women with triple negative breast cancer, it’s possible to tell how likely the disease is to spread to other parts of the body.

Read the full story